Skip to main content

TiO2 makers head for court over unpaid fee

20th May 2019

Submitted by:

Andrew Warmington

Venator Materials, a global supplier of pigments and performance additives, has started a lawsuit against Tronox in the Delaware Superior Court, claiming that Tronox has refused to honour a contract to pay a $75 million ‘break fee’ for the termination of the proposed sale of Cristal’s North American titanium dioxide (TiO2) business. Tronox has retorted that it is not obliged to do so because Venator did not negotiate in good faith.

The US Federal Trade Commission (FTC) had required Tronox to sell the assets at Ashtabula, Ohio, in order to resolve competition concerns arising from its proposed merger with Cristal. It entered into talks with UK-based Venator but in the end sold the operation to Ineos, although it did complete the much smaller sale of the 8120 paper-laminate product grade to Venator in order to win approval of the deal in the EU.

Venator president and CEO Simon Turner said that Tronox “has failed to honour its contract with Venator and offers baseless excuses for its refusal to perform”. Tronox, he added, had abruptly terminated bilateral discussions to pursue an alternative transaction while Venator was preparing to respond to the FTC’s concerns. The break fee was due to be paid on 13 May. Venator is also demanding payment of pre- and post-judgement interest and legal fees and costs. However, Jeffry Quinn, chairman and CEO of

Tronox, which is the world’s largest vertically integrated producer of the white pigment, counter-alleged that Venator failed to adhere to the terms of the memorandum of understanding (MoU) between the two, which envisaged a $1.1 billion deal. This ultimately forced Tronox to accept a much lower bid of $700 million from Ineos, which, he said, obviates any requirement to pay the break fee.

“Despite our fundamental disagreement over the consequences of Venator’s actions under the MoU, it is our hope to resolve this matter through negotiation, but are prepared to defend our position if necessary,” added Quinn. “Tronox will instead continue to focus on unlocking the substantial value created by our transformative acquisition of Cristal for the benefit of our shareholders, customers and employees.”

The sale of the 8120 grade, which was agreed in July 2018 along with the break fee, was completed on 10 April. Of €8 million fee, €1 million has been paid already and the rest will be paid in even instalments in Q2 2020 and Q2 2021. A transitional supply agreement is in effect until the manufacturing transfer is completed. The sale of the Cristal operations to Ineos was completed on 1 May.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington